GUILLERMO
LÓPEZ VIVANCO
Ikertzailea 2022-(e)ra arte
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosUniversity of Texas MD Anderson Cancer Center-ko ikertzaileekin lankidetzan egindako argitalpenak (3)
2020
-
Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial
The Lancet Oncology, Vol. 21, Núm. 11, pp. 1413-1422
2012
2003
-
Chemotherapy for Bladder Cancer [6] (multiple letters)
New England Journal of Medicine